Subscriber Content Read Preview
Silverfleet Capital, the Europe-focused private-equity firm, plans to announce Wednesday that it is selling health-care-services firm Sterigenics International to U.S. buyout firm GTCR for $675 million.
Subscriber Content Read Preview
The Supreme Court ruled that federal law shields vaccine makers from some types of product-liability lawsuits.
Subscriber Content Read Preview
Novartis narrowly won investor backing for its compensation system amid persistent shareholder calls for the Swiss drug giant to change its remuneration practices and curb payouts.
Subscriber Content Read Preview
Forest Laboratories it will buy Clinical Data for at least $1.2 billion.
Subscriber Content Read Preview
Indian drug maker Ranbaxy Laboratories posted a five-fold jump in profit for 2010, helped by gains. Sales rose 16%.
Subscriber Content Read Preview
Subscriber Content Read Preview
Subscriber Content Read Preview
Subscriber Content Read Preview
View an interactive map that shows you how stocks in the Pharmaceuticals & Biotech sector are doing today, at a glance.
Get in-depth research on Pharmaceuticals & Biotech companies, including complete news and financials, earnings estimates and more.
Ask a question about anything you choose, and let readers from the Journal Community answer it.
Hello
Your question to the Journal Community Your comments on articles will show your real name and not a username.Why?
Create a Journal Community profile to avoid this message in the future. (As a member you agree to use your real name when participating in the Journal Community)